Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of XOMA 358 in healthy volunteers.

Trial Profile

Phase I trial of XOMA 358 in healthy volunteers.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 15 Sep 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs RZ 358 (Primary)
  • Indications Hyperinsulinaemia; Hypoglycaemia; Insulinoma
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
  • Sponsors XOMA
  • Most Recent Events

    • 15 Sep 2016 According to XOMA media release, updates from this and other three studies of XOMA-358 were presented in a webcast on 15 Sep 2016.
    • 11 Mar 2015 Status changed from recruiting to completed, according to a XOMA Corporation media release.
    • 08 Mar 2015 Results presented at The 97th Annual Meeting of the Endocrine Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top